8 research outputs found

    Effect of biomass on assemblages of large mammals in a seasonally dry forest in the Brazilian Amazonia

    No full text
    Aiming to understand the relationship between body mass and abundance, a community of middle-sized and larger mammals was studied in a seasonally dry forest in the far north of the Brazilian Amazonia. Diurnal and nocturnal surveys were carried out by the line-transect method along a 10-km transect. Data were collected on density, biomass, use of forest types, forest strata, diet and feeding strategies by the mammals. Biomass explained animal abundance better than did body mass across the two forest types: Terra Firme forest and mixed forest. There was a statistically significant positive relationship between the biomass of all the 33 mammals studied and group density, as well as between biomass and group size, in both forests. When terrestrial and arboreal mammals, and also different feeding guilds were considered separately, they exhibited very similar results, where biomass alone was positively associated with group density and group size. The slope of the relationships between body mass and group density, body mass and group size, biomass and group density, and biomass and group size varied considerably, with significant scatter around the regression line. Food and food competition shaped the relationship between animal mass and abundance, and this relationship can even vary widely between assemblages. As a result of competition for the available resources, group density increased with increasing biomass

    Sustained IGF-1 Secretion by Adipose-Derived Stem Cells Improves Infarcted Heart Function

    No full text
    The mechanism by which stem cell-based therapy improves heart function is still unknown, but paracrine mechanisms seem to be involved. Adipose-derived stem cells (ADSCs) secrete several factors, including insulin-like growth factor-1 (IGF-1), which may contribute to myocardial regeneration. Our aim was to investigate whether the overexpression of IGF-1 in ADSCs (IGF-1-ADSCs) improves treatment of chronically infarcted rat hearts. ADSCs were transduced with a lentiviral vector to induce IGF-1 overexpression. IGF-1-ADSCs transcribe100- to 200-fold more IGF-1 mRNA levels compared to nontransduced ADSCs. IGF-1 transduction did not alter ADSC immunophenotypic characteristics even under hypoxic conditions. However, IGF-1-ADSCs proliferate at higher rates and release greater amounts of growth factors such as IGF-1, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) under normoxic and hypoxic conditions. Importantly, IGF-1 secreted by IGF-1-ADSCs is functional given that Akt-1 phosphorylation was remarkably induced in neonatal cardiomyocytes cocultured with IGF-1-ADSCs, and this increase was prevented with phosphatidylinositol 3-kinase (PI3K) inhibitor treatment. Next, we tested IGF-1-ADSCs in a rat myocardial infarction (MI) model. MI was performed by coronary ligation, and 4 weeks after MI, animals received intramyocardial injections of either ADSCs (n = 7), IGF-1-ADSCs (n = 7), or vehicle (n = 7) into the infarcted border zone. Left ventricular function was evaluated by echocardiography before and after 6 weeks of treatment, and left ventricular hemodynamics were assessed 7 weeks after cell injection. Notably, IGF-1-ADSCs improved left ventricular ejection fraction and cardiac contractility index, but did not reduce scar size when compared to the ADSC-treated group. In summary, transplantation of ADSCs transduced with IGF-1 is a superior therapeutic approach to treat MI compared to nontransduced ADSCs, suggesting that gene and cell therapy may bring additional benefits to the treatment of MI
    corecore